Correlation Between NYSE Composite and Erytech Pharma

Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Erytech Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Erytech Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NYSE Composite and Erytech Pharma SA, you can compare the effects of market volatilities on NYSE Composite and Erytech Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Erytech Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Erytech Pharma.

Diversification Opportunities for NYSE Composite and Erytech Pharma

-0.11

Correlation Coefficient

NYSE Composite  Erytech Pharma

Good diversification

The 3 months correlation between NYSE and Erytech is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Erytech Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erytech Pharma SA and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Erytech Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erytech Pharma SA has no effect on the direction of NYSE Composite i.e., NYSE Composite and Erytech Pharma go up and down completely randomly.

Pair Corralation between NYSE Composite and Erytech Pharma

If you would invest  1,901,742  in NYSE Composite on September 1, 2024 and sell it today you would earn a total of  125,462  from holding NYSE Composite or generate 6.6% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

NYSE Composite  vs.  Erytech Pharma SA

Pair Trading with NYSE Composite and Erytech Pharma

The main advantage of trading using opposite NYSE Composite and Erytech Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Erytech Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erytech Pharma will offset losses from the drop in Erytech Pharma's long position.

The idea behind NYSE Composite and Erytech Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.